SB 612111 is a potent and selective antagonist of the nociceptin/orphanin FQ receptor, serving as a critical research tool for investigating opioid receptor pharmacology and pain signaling pathways. By… Read more
SB 612111 is a potent and selective antagonist of the nociceptin/orphanin FQ receptor, serving as a critical research tool for investigating opioid receptor pharmacology and pain signaling pathways. By functioning as a high-affinity ligand, this compound allows researchers to study complex physiological mechanisms without activating traditional mu-opioid receptors. Analytical laboratories rely on high-quality reference standards of this molecule, along with its associated impurities and stable isotope-labelled derivatives such as SB 612111-d4 hydrochloride, to ensure accurate results in complex matrices. These compounds are essential for rigorous impurity profiling, method validation, and precise quantitative analysis during pharmacological research and drug development. Utilizing these standardized materials ensures consistency in chromatographic techniques, such as LC-MS and HPLC, enabling the sensitive detection and quantification necessary for assessing the stability and chemical integrity of the active pharmaceutical ingredient.